SciELO - Scientific Electronic Library Online

 
vol.149 número6Adherencia a las recomendaciones de tromboprofilaxis post-cesárea: estudio de corte transversalParacetamol como coadyuvante a opioides fuertes en dolor oncológico moderado a intenso: ¿es realmente efectivo? índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

CARRILLO, Diego et al. Update on neuroendocrine tumors. Rev. méd. Chile [online]. 2021, vol.149, n.6, pp.888-898. ISSN 0034-9887.  http://dx.doi.org/10.4067/s0034-98872021000600888.

Neuroendocrine Tumors (NETs) encompass a wide variety of tumors arising from neuroendocrine cells, which produce bioactive substances. The incidence of NETs increased significantly lately, becoming one of the most common tumors of the digestive tract. Their clinical presentation is as diverse as their capacity for hormone production. Carcinoid syndrome is the most common hormonal syndrome produced by NETs and is characterized by diarrhea, flushing and cardiac valvular lesions. New research brought multiple changes in the classification of these neoplasms and a new understanding about their diagnosis and treatment, promoting a multidisciplinary approach. Somatostatin analogues, radiation, biological, and cytotoxic drugs have improved the prognosis of these patients, which entails a great challenge for healthcare providers.

Palabras clave : Biomarkers, Tumor; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Somatostatin.

        · texto en Español     · Español ( pdf )